Exponent, Inc.
$89.16+$0.16 (+0.2%)
Last close · Data as of Nov 20, 2026
- Market cap
- $2.9B
- P/E
- 27.2x
- EV / EBITDA
- 21.1x
- Revenue
- $582.0M
- Net margin
- 18.2%
- ROCE
- 30.7%
Price chart
Technical chartScreen technicals →+30.0% over the last year
Daily closes.
Go deeper
Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes
Performance
Price return, before dividends, to the 20 Nov 2026 close.
- 1M
- +22.9%
- 3M
- +28.5%
- 6M
- +53.1%
- 1Y
- +30.0%
- 5Y
- -28.7%
52-week range
Day change +$0.16 (+0.2%) from $89 to $89 · Last close Nov 20, 2026
Best weekday to invest, historically
The same weekly amount in EXPO, bought on each weekday since 2021.
News & filings
What Exponent filed, who traded, and what's next
How to read this
"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.
AI Summary
US StockStrengthNet margin of 18.2% against a peer median of 1.4%.
Concerns (1)
- The P/E of 27.2 is 279% above the peer median of 7.2.
Prices to the 20 Nov 2026 close · Financial year: fiscal 2025
Rule-based from financial data. Not advice.
About the company
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health.
Read moreShow less
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, metallurgical and corrosion engineering polymer and chemistry, thermal sciences, and vehicle engineering. The company also offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. In addition, it provides proactive and reactive product safety, litigation support, and technical, regulatory services. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.
- Sector
- Industrials
- Shares outstanding
- 49.6M
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- $2.9B
- P/E
- 27.2x
- P/B
- 7.4x
- EV / EBITDA
- 21.1x
- EV / Sales
- 4.7x
- P/S
- 5.0x
- 52-week high
- $89.16
- 52-week low
- $53.67
Profitability
- Operating margin
- 20.6%
- Net margin
- 18.2%
- EBITDA margin
- 22.3%
- ROE
- 27.2%
- ROCE
- 30.7%
- ROIC
- 34.3%
- ROA
- 13.6%
- Asset turnover
- 0.75
Growth
- RevenueFY2025, the latest fiscal year in the company's growth history.
- $582.0M
- Revenue growth, 1YFY2025, the latest fiscal year in the company's growth history.
- 4.2%
- Revenue CAGR, 3YFY2025, the latest fiscal year in the company's growth history.
- 4.3%
- Net profit growth, 1YFY2025, the latest fiscal year in the company's growth history.
- -2.7%
- Free cash flowFY2025, the latest fiscal year in the company's growth history.
- $122.3M
Solvency
- Current ratio
- 2.40
- Debt / Equity
- 0.21
- Debt / Assets
- 0.11
- CFO / Net profit
- 1.24
- Cash / Market cap
- 7.7%
Where the revenue went
Of every $100 of FY2025 revenue, $18 was left as net income.
| From | To | Amount |
|---|---|---|
| Revenue | Gross profit | $582.0M |
| Gross profit | Selling, general and administrative | $367.5M |
| Gross profit | Other operating expenses | $94.7M |
| Gross profit | Operating income | $119.8M |
| Operating income | Pretax income | $119.8M |
| Interest and other income | Pretax income | $27.5M |
| Pretax income | Tax and other | $41.3M |
| Pretax income | Net income | $106.0M |
Revenue and net profit
Revenue grew 4.2% in FY2025; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2022 | $513.3M | $102.3M |
| FY2023 | $536.8M | $100.3M |
| FY2024 | $558.5M | $109.0M |
| FY2025 | $582.0M | $106.0M |
Cash flows
FY2025: $131.7M from operations, $122.3M free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2022 | $93.8M | $81.8M |
| FY2023 | $127.4M | $111.0M |
| FY2024 | $144.5M | $137.6M |
| FY2025 | $131.7M | $122.3M |
Growth
Latest fiscal year 2025: each figure with its change over the year before.
- Revenue
- $582.0M+4.2%1Y
- EBITDA
- $129.9M+0.5%1Y
- Net profit
- $106.0M-2.7%1Y
- Cash from operations
- $131.7M-8.9%1Y
- Free cash flow
- $122.3M-11.1%1Y
- Revenue CAGR, 3Y
- 4.3%
- Net profit CAGR, 3Y
- 1.2%
| Year | Revenue | EBITDA | Net profit | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|
| FY2025 | $582.0M | $129.9M | $106.0M | $122.3M | 27.2% | +4.2% | -2.7% |
Monthly returns
Month-by-month returns of EXPO across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2025.
| Line | FY2025 |
|---|---|
| Assets | $777.5M |
| Current assets | $427.6M |
| Non-current assets | $349.9M |
| Liabilities | $387.2M |
| Current liabilities | $178.0M |
| Non-current liabilities | $209.2M |
| Equity | $390.3M |
| Paid-in capital | $369.8M |
| Retained earnings | $668.4M |
| Treasury stock | $645.6M |
Market cap against peers
8 peers: same sector, nearest by size.
Peers map
Industrials companies placed by value, growth and quality; EXPO highlighted.
P/E against peers
EXPO trades at 27.2x earnings against a peer median of 7.2x (a 279% premium).
Not shown (no positive earnings and no EV / Sales): Atkore Inc., Voyager Technologies, Inc., Eos Energy Enterprises, Inc., First Advantage Corporation.
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| Exponent, Inc.EXPOthis companyP/E ↑ premium | $2.9B | 27.2x | 7.4x | 27.2% | 21.1x |
| Astronics CorporationATRO | $3.1B | 106.6x | 22.3x | 21.0% | 35.5x |
| CECO Environmental Corp.CECO | $2.9B | 58.1x | 9.2x | 15.8% | 24.2x |
| Atkore Inc.ATKR | $2.9B | -189.0x | 2.1x | -1.1% | 18.9x |
| Helios Technologies, Inc.HLIO | $2.8B | 58.7x | 3.0x | 5.2% | 21.3x |
| Voyager Technologies, Inc.VOYG | $2.8B | -27.0x | 7.4x | -27.3% | -31.3x |
| Eos Energy Enterprises, Inc.EOSE | $2.7B | -2.8x | -1.2x | 43.3% | -3.2x |
| First Advantage CorporationFA | $2.7B | -77.7x | 2.1x | -2.7% | 12.0x |
| McGrath RentCorpMGRC | $2.7B | 17.2x | 2.2x | 12.6% | 9.1x |
| Peer median | — | 7.2x | 2.6x | 8.9% | 15.4x |
Year-to-date ROI
EXPO since 1 January, against earlier years.
Historical volatility
EXPO's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.
Consolidated figures in USD, fiscal years, newest first.
Operating margin by fiscal year
| Date | Operating margin |
|---|---|
| FY2022 | 27.4% |
| FY2023 | 20.7% |
| FY2024 | 21.4% |
| FY2025 | 20.6% |
| Line | FY2025 |
|---|---|
| RevenueTotal Revenue | $582.0M |
| Operating expensesOperating Expense | $462.2M |
| Selling, general and administrativeSelling General And Administration | $367.5M |
| Other operating expensesOther Operating Expenses | $94.7M |
| Total expensesTotal Expenses | $462.2M |
| Operating incomeOperating Income | $119.8M |
| Interest and other | |
| Pretax incomePretax Income | $147.3M |
| TaxTax Provision | $41.3M |
| Net incomeNet Income | $106.0M |
| Per share | |
| Supplementary |
| Line | FY2025 |
|---|---|
| AssetsTotal Assets | $777.5M |
| Current assetsCurrent Assets | $427.6M |
| Non-current assetsTotal Non Current Assets | $349.9M |
| LiabilitiesTotal Liabilities Net Minority Interest | $387.2M |
| Current liabilitiesCurrent Liabilities | $178.0M |
| Non-current liabilitiesTotal Non Current Liabilities Net Minority Interest | $209.2M |
| EquityTotal Equity Gross Minority Interest | $390.3M |
| Supplementary |
| Line | FY2025 |
|---|---|
| Operating cash flowOperating Cash Flow | $131.7M |
| Cash from continuing operationsCash Flow From Continuing Operating Activities | $131.7M |
| Net income, continuing operationsNet Income From Continuing Operations | $106.0M |
| Depreciation and amortisationDepreciation And Amortization | $10.1M |
| Depreciation, amortisation and depletionDepreciation Amortization Depletion | $10.1M |
| Depreciation | $10.1M |
| Amortization of securitiesAmortization Of Securities | — |
| Stock-based compensationStock Based Compensation | $23.8M |
| Deferred taxDeferred Tax | -$9.9M |
| Deferred income taxDeferred Income Tax | -$9.9M |
| Provision and write off of assetsProvisionand Write Offof Assets | $3.0M |
| Change in working capitalChange In Working Capital | -$1.2M |
| Investing cash flowInvesting Cash Flow | -$9.4M |
| Cash from continuing investingCash Flow From Continuing Investing Activities | -$9.4M |
| Capital expenditureCapital Expenditure | -$9.4M |
| Capital expenditure (reported)Capital Expenditure Reported | -$9.4M |
| Purchase of investmentsPurchase Of Investment | — |
| Sale of investmentsSale Of Investment | — |
| Net investment purchases and salesNet Investment Purchase And Sale | — |
| Financing cash flowFinancing Cash Flow | -$160.4M |
| Cash from continuing financingCash Flow From Continuing Financing Activities | -$160.4M |
| Net common stock issuedNet Common Stock Issuance | -$97.1M |
| Common stock repurchasedCommon Stock Payments | -$97.1M |
| Share buybacksRepurchase Of Capital Stock | -$97.1M |
| Stock options exercisedProceeds From Stock Option Exercised | $2.4M |
| Dividends paidCash Dividends Paid | -$61.5M |
| Common dividends paidCommon Stock Dividend Paid | -$61.5M |
| Other financing chargesNet Other Financing Charges | -$4.2M |
| Change in cashChanges In Cash | -$38.1M |
| Effect of exchange ratesEffect Of Exchange Rate Changes | 112.0% |
| Cash at the start of the yearBeginning Cash Position | $258.9M |
| Cash at the end of the yearEnd Cash Position | $221.9M |
| Free cash flowFree Cash Flow | $122.3M |
| Supplemental |
Learn while you research
Academy chapters picked for Exponent, Inc. and the metrics on this page.
- 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 02 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
- 03 Business Cycles & StocksThese cyclical sectors win and lose in different macro phases.6 min read
- 04 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
- 05 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read